Marketable Securities |
Marketable Securities A summary of the Company’s cash, cash equivalents and marketable securities is shown below: | | | | | | | | | | | | | | | | | | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | (in thousands) | As of June 30, 2017 | | | | | | | | Cash and cash equivalents: | | | | | | | | Cash and money market funds | $ | 1,217,134 |
| | $ | — |
| | $ | — |
| | $ | 1,217,134 |
| Commercial paper | 5,996 |
| | — |
| | — |
| | 5,996 |
| Total cash and cash equivalents | $ | 1,223,130 |
| | $ | — |
| | $ | — |
| | $ | 1,223,130 |
| Marketable securities: | | | | | | | | Corporate equity securities | 43,213 |
| | 7,836 |
| | — |
| | 51,049 |
| Commercial paper (matures within 1 year) | 103,386 |
| | 1 |
| | (40 | ) | | 103,347 |
| Corporate debt securities (matures within 1 year) | 218,216 |
| | 4 |
| | (143 | ) | | 218,077 |
| Corporate debt securities (matures after 1 year) | 73,115 |
| | 2 |
| | (70 | ) | | 73,047 |
| Total marketable securities | $ | 437,930 |
| | $ | 7,843 |
| | $ | (253 | ) | | $ | 445,520 |
| Total cash, cash equivalents and marketable securities | $ | 1,661,060 |
| | $ | 7,843 |
| | $ | (253 | ) | | $ | 1,668,650 |
| | | | | | | | | As of December 31, 2016 | | | | | | | | Cash and cash equivalents: | | | | | | | | Cash and money market funds | $ | 1,183,945 |
| | $ | — |
| | $ | — |
| | $ | 1,183,945 |
| Total cash and cash equivalents | $ | 1,183,945 |
| | $ | — |
| | $ | — |
| | $ | 1,183,945 |
| Marketable securities: | | | | | | | | Government-sponsored enterprise securities (matures within 1 year) | $ | 15,506 |
| | $ | 2 |
| | $ | — |
| | $ | 15,508 |
| Corporate equity securities | 43,213 |
| | 21,347 |
| | — |
| | 64,560 |
| Commercial paper (matures within 1 year) | 59,331 |
| | 73 |
| | — |
| | 59,404 |
| Corporate debt securities (matures within 1 year) | 111,225 |
| | — |
| | (85 | ) | | 111,140 |
| Total marketable securities | $ | 229,275 |
| | $ | 21,422 |
| | $ | (85 | ) | | $ | 250,612 |
| Total cash, cash equivalents and marketable securities | $ | 1,413,220 |
| | $ | 21,422 |
| | $ | (85 | ) | | $ | 1,434,557 |
|
The Company has a limited number of marketable securities in insignificant loss positions as of June 30, 2017, which the Company does not intend to sell and has concluded it will not be required to sell before recovery of the amortized costs of the investment at maturity. There were no charges recorded for other-than-temporary declines in fair value of marketable securities nor gross realized gains or losses recognized in the three and six months ended June 30, 2017 and 2016.
|